AI assistant
Sending…
Anterix Inc. — Director's Dealing 2025
Jan 22, 2025
33018_dirs_2025-01-22_0c221123-f3a0-4679-aa7d-8c785ce31f9e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2025-01-17
Reporting Person: Lang Scott A. (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-17 | Stock Option (Right to Buy) | $30.99 | A | 191326 | Acquired | 2026-01-17 | Common Stock (191326) | Direct |
Footnotes
F1: The shares subject to the option shall vest and become exercisable in three annual installments with vesting commencing on January 17, 2025, subject to the Reporting Person's continuous services to the Issuer through each such vesting date.
More from Anterix Inc.
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 19